Short-Term Debt to Capital: Illumina Inc (ILMN)

Brandmark of Illumina, Inc. (ILMN)

Illumina, Inc. (ILMN) is implementing eco-design and striving for full energy autonomy by 2030. The short-term accounts payable-to-capital ratio reflects current debt obligation trends. Business stability relies on low-cyclical demand and grant support. The "razor-and-blade" model cements laboratory dependence on consumables. The value of 0.03 serves as the final level mark.

ILMN - Illumina Corp Short-Term Debt to Capital over the range 07/04/2022 - 11/01/2026
Brand item of Illumina

This indicator measures the proportion of short-term liabilities with maturities of up to one year relative to equity. The metric allows for tracking the risk of cash flow gaps between quarterly reports. By analyzing the volume of short-term loans relative to equity, an investor can assess a company's resilience to market downturns. For Illumina, Inc. (ILMN), the stabilization of cash flow following asset restructuring minimizes the core business's dependence on such borrowings.

Competitors of Illumina, Inc. (ILMN)

Short-Term Debt to Capital A|DGX - Current Liabilities to Capital|Short-Term Debt to Capital EXAS (Exact Sciences)|RVTY: Short-Term Debt to Capital Ratio|Bio-Rad - Short-Term Debt to Capital|NNNN - Short-Term Debt to Capital|Sterigenics (SHC) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio QDEL|OPK (OPKO Health, Inc.) - Short-Term Debt to Capital|Short-Term Debt to Capital CareDx Corp|Short-Term Debt to Equity Maravai LifeSciences Holdings, Inc. (MRVI)|Short-Term Debt to Equity FLGT (Fulgent Genetics Inc)|Fluidigm - Short-Term Debt to Equity Ratio|Cytek Corp (CTKB) - Current Liabilities to Capital|OSUR - Short-Term Debt to Equity|Short-Term Debt to Capital Coefficient Exagen Inc. XGN|MDXH: Short-Term Debt to Capital|LUCD - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Prenetics Global Limited|Insight Molecular (IMDX) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Capital TRIB|Short-Term Debt to Capital Coefficient prophaselabs.com|Short-Term Debt to Equity Ainos AIMD|Co-Diagnostics Inc - Short-Term Debt to Equity|HSCS - Short-Term Debt to Equity|BMRA: Short-Term Debt to Equity|CDIO (cardiodiagnosticsinc.com) - Short-Term Debt to Equity Ratio|viraxbiolabs.com (VRAX) - Short-Term Debt to Capital|Short-Term Debt to Equity Bluejay Diagnostics, Inc.|Short-Term Debt to Equity Ratio Aspira Women's Health, Inc. (AWH)|Short-Term Debt to Capital AXDX|Short-Term Debt to Capital Coefficient Centogene|Short-Term Debt to Equity Enzo Biochem ENZ|FRES: Short-Term Debt to Capital Ratio|GTG Labs - Short-Term Debt to Capital|ME - Short-Term Debt to Capital|PMD (Psychemedics Corp) - Short-Term Debt to Equity Ratio